Christine D. Berg, M.D. currently serves as a Special Volunteer to the Director, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health. She is an advisor to GRAIL, Inc https://grail.com/ and a consultant to Mercy Bioanalytics https://mercybio.com/ . Her research efforts focus on cancer risk-based assessment and how to integrate molecular epidemiology and then move these efforts into the clinical arena. She is the former Chief, Early Detection Research Group, Division of Cancer Prevention, National Cancer Institute. In this position, she was Project Officer for the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial (PLCO) and the National Lung Screening Trial (NLST). She previously worked at Suburban Hospital as the Cancer Center Director and at the Georgetown University Medical School Lombardi Cancer Center as the head of breast cancer radiation oncology and as director of the residency training program. She attended Northwestern University in the Honors Program in Medical Education receiving her B.S. and M.D. in six years. She is board certified in Internal Medicine, Medical Oncology and Radiation Oncology.
Additional activities focus on adaptation and mitigation of the public health effects of the climate crisis. She serves on the Board of Public Employees for Environmental Responsibility www.peer.org She is a member of the Climate Victory Council of the League of Conservation Voters and volunteers for the Sierra Club and Elders Climate Action. She has recently joined the Cosmos Club https://www.cosmosclub.org/ in Washington DC where she participates actively in the Climate Change Group and the Natural Resources Group.

Karen is an epidemiologist and modeler. She leads the Cancer Research Division at Cancer Council NSW Australia, and is the Director of The Daffodil Centre, a joint venture with The University of Sydney. The focus of her program of research is to provide policy-makers with an evidence-base for decision making in cancer control. Karen has led evaluations of new screening approaches for government agencies in several countries. Her team’s work underpins the transition of the National Cervical Screening Program in Australia to 5-yearly HPV-based screening and has supported several other countries in considering a transition to HPV-based cervicl screening. She currently has active collaborative modelling grants from the US NIH and WHO to model cancer prevention in the USA and globally. She is also co-chair of the Steering Group for the Covid-19 and Cancer Global Modelling Consortium (CCGMC.org) which is supported by UICC, the International Agency for Research on Cancer, The International Cancer Screening Network, and the Canadian Partnership against Cancer. The CCGMC aims to quantify the global impact of the pandemic and assist in recovery planning for cancer outcomes.